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Background: Chronic obstructive pulmonary disease (COPD) is a condition in which there 
is limited airflow during expiration (exhaling, or breathing out) that is not fully reversible and 
usually worsens over time. The disease is estimated to kill more than 100,000 Americans each 
year, and costs related to care of patients with COPD are significant. Physiologically, COPD 
represents a disruption in ventilation and in the exchange of gases in the lungs. Laboratory tests 
indicate elevated CO2 levels, gradual reduction of the levels of oxygen and pH in arterial blood, 
and a consequent rise in the dead space fraction (DSF) of the lungs.
Objective: Patients with COPD exacerbation represent a large portion of those artificially 
ventilated. In an attempt to develop a prognostic tool for length of treatment, we compared the 
proportion of DSF to the length of mechanical ventilation (MV).
Methods: This study included 73 patients admitted to the intensive care unit (ICU) where they 
received MV due to exacerbation of COPD. Each patient’s arterial blood gases (ABG) were 
measured upon admission. PeCO2 was tested using a Datex S/5 instrument. Subsequently, DSF 
was calculated using the Bohr equation. Statistical data was analyzed using SPSS software.
Results: Patients included in the study were ventilated from 6 to 160 hours (average 40 ± 47). 
In addition to ABG measurements, PeCO2 (expired CO2) levels were measured and DSF 
calculated for each patient. DSF values varied from 0.21 to 0.76 (average 0.119 ± 0.489). No 
correlation was found between DSF and length of artificial ventilation.
Conclusion: Evaluation of DSF does not provide a factor in estimating the length of treatment 
for patients with acute respiratory failure due to COPD exacerbation.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a leading cause of worldwide 
disability and mortality. An average of 5%–15% of adults in industrialized countries 
have COPD defined by clinical symptoms and spirometry.1–3 In 1990, COPD was ranked 
twelfth worldwide as a cause of combined disability and mortality but is expected to 
rise to fifth by the year 2020. COPD has a chronic long-lasting course characterized 
by irreversible decline of forced expiratory volume in one second (FEV1), increasing 
presence of dyspnea and other respiratory symptoms, and progressive deterioration 
of health status. After diagnosis the 10-year survival rate is approximately 50% with 
more than one-third of patients dying due to respiratory insufficiency.2 The etiology 
of COPD is overwhelmingly dominated by smoking although many other factors 
can play a role. Particular genetic variants are likely to increase the susceptibility to 
environmental factors although little is known about which are the relevant genes. International Journal of COPD 2009:4 438
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Although there is accumulating evidence that oxygen therapy, 
pharmacological treatment and rehabilitation may improve 
the course of COPD, abstaining from smoking continues to 
be the most relevant measure, not only in preventing COPD, 
but also in arresting its development.4–6
The admission of COPD exacerbation patients to an 
intensive care unit (ICU) is common, as 26%–74% of them 
need mechanical ventilation (MV). Few studies have been 
conducted to assess the value of physiological factors as a 
weaning predictor. The recording of dead space will give infor-
mation on how much total ventilation reaches both ventilated 
and perfused alveoli and thus allows gas exchange between 
alveoli and pulmonary blood. CO2 retention can be a result 
not only of low total ventilation but also of increased dead 
space. Correct measurement and calculation of the dead space 
will give valuable information on the ventilatory support of 
the critically ill patient and can also be a valuable diagnostic 
tool. It should therefore not be forgotten in the intensive care 
setting. The aim of this study was to assess whether the length 
of MV in patients with COPD exacerbation can be predicted 
by the measurement of dead space fraction (DSF).
Patients and methods
This study was conducted in the respiratory ICU of Nahariya 
Hospital during an eight-month period (from September 
2007–May 2008). Seventy-three patients (52 males 71%; 
21 females, 29%) with a history and clinical findings of 
COPD who were admitted to the respiratory ICU with 
respiratory failure due to COPD exacerbation and needed 
MV were eligible for the study. All these patients had not 
responded to noninvasive ventilation and were intubated 
before their admission to the ICU. Data were collected in 
all patients requiring MV; criteria used were similar to the 
GOLD guidelines for intubations.7 The following information 
was recorded: age, gender, smoking history, co-morbidity, 
pulmonary function tests. Age range was 40 to 96 years, with 
mean age 70 years (standard deviation [SD] ± 11).
The institutional committee in accordance with the 
Helsinki declaration approved an informed consent for 
blood sampling and signed informed consent by the patients. 
COPD exacerbation was clinically evaluated and diagnosed 
according to known criteria (exacerbation of cough, purulent 
sputum production, severe dyspnea and negative response to 
bronchodilators).1,7 Radiological imaging showed no signs of 
pneumonia or congestive heart failure. Each patient’s arterial 
blood gases (ABG) were measured upon admission and ECG 
was performed, as were arterial blood gas measurements. 
PeCO2 was tested using a Datex S/5 instrument. Subsequently 
DSF was calculated for each patient using the Bohr equation: 
DSF = (PaCO2–PeCO2)/PaCO2 with normal value less 
than 0.3,8,9 where PeCO2 is the partial pressure of carbon 
dioxide in mixed expired gas and is equal to the mean expired 
carbon dioxide fraction multiplied by the difference between 
the atmospheric pressure and the water-vapor pressure. All 
patients were under cardiac and respiratory monitoring (heart 
rate, respiratory rate, O2 saturation and PeCO2). All patients 
received treatment with bronchodilators, corticosteroids and 
sedative therapy such as propofol.
statistical analysis
Statistical analysis was performed using SPSS software 
(v. 11; SPSS Inc, Chicago, IL, USA).
Data are expressed as mean ± standard error of mean. Dif-
ferences in mean values were tested by two-way analysis of 
variance (ANOVA) and by the Bonferroni Multiple comparison 
test, using Prism version 3.0 statistical software (GraphPad, 
San Diego, CA, USA). Correlations between different study 
parameters were performed alone using Pearson correlation 
coefficients. P  0.05 was considered significant.
Results
The clinical and biochemical parameters of ventilated 
patients with COPD exacerbation on admission are depicted 
in Table 1, and the correlation of the data shown in Table 2.
The duration of MV was between 6 and 160 hours, 
mean 47 ± 40. Most of the patients were weaned from 
MV by 70 hours (82%); 33 of the patients (67.3%) were 
weaned from MV within 24 hours.
Table 1 summary of all results
Values Results
gender Male 52 (71.4%)
Female 29 (28.6%)
Age (Year) Mean (std) 70.6
ph Mean (std) 7.15 ± 0.08
PaO2 mmhg Mean (std) 91.47 ± 60.25
PaCO2 mmhg Mean (std) 90 ± 16
Bicarbonate meq/l Mean (std) 30.8 ± 6.68
O2  – saturation % Mean (std) 86.2 ± 10.9
PeCO2 mmhg Mean (std) 45.0 ± 11.29
Respiratory rate Mean (std) 18.18 ± 7.9
DsF Mean (std) 0.49 ± 0.12
Duration of MV (hours) Mean (std) 47.39 ± 40.07
Notes:  This table shows the mean of 73 patients’ parameters on admission to intensive 
care unit (all of them on MV) and the duration of MV in hours.
Abbreviations: DsF, dead space fraction; MV, mechanical ventilation; O2, oxygen 
saturation in arterial blood; PaO2, partial pressure of oxygen in arterial blood; 
PaCO2, partial pressure of carbon dioxide in arterial blood.International Journal of COPD 2009:4 439
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Value of blood pH from all patients varied between 6.98–7.28 
(mean 7.15 ± 0.08). There was no correlation between pH 
value and the duration of MV , and statistically was not sig-
nificant (P = 0.179). Patients with very low PH were weaned 
within 5–7 hours from MV and vice versa.
PaO2
Arterial PO2 was 33–395 mmHg (mean 91 ± 60). Patients 
were ventilated with a different O2 concentration to maintain 
acceptable blood PaO2 and O2 saturation (86%).10 During 
the initial period of admission O2 saturation was 56%–99% 
(mean 86 ± 11).
PaCO2
PaCO2 was between 52–126 mmHg (mean 90 ± 16). There 
was no correlation between these values and the duration of 
mechanical ventilation.
PeCO2
This tool gives us a picture of the ventilated lung; high values 
indicate poor lung ventilation that requires prolonging the 
mechanical ventilation period. PeCO2 was measured in all 
patients in the study using a Datex S/5 instrument; the values 
in this study were 25–70 (mean 45 ± 11).
DsF
Using the Bohr equation the average DSF in our study varied 
from 0.22 to 0.74 (average 0.489 ± 0.119) while the normal 
values are usually less than 0.3. There is an inverse relation-
ship between the changes in DSF compared to blood acidosis 
level, (P = 0.004) considered statistically significant. A low 
level of DSF means a higher PH level, but when the acidosis 
is near normal range the DSF level is also near normal. There 
was good correlation between DSF and PaCO2, (P = 0.009) 
considered statistically significant.
Our results show that no correlation was found between 
DSF and length of artificial ventilation, these findings do 
not contribute to the evaluation of the patient’s condition 
nor do they enable us to predict the length of mechanical 
ventilation (P = 0.295).
Discussion
Patients with COPD may require mechanical ventila-
tion for the treatment of respiratory failure during acute 
exacerbations. Usually we try to treat these patients with 
noninvasive positive pressure ventilation that should always 
be considered when there is a need for ventilation assistance, 
as indicated by such symptoms as worsened dyspnea, acute 
respiratory acidosis and worsened oxygenation (eg, ratio of 
PaO2 of the fraction of inspired oxygen of less than 200), are 
Those patients with respiratory arrest, any medical instability 
or hypotensive shock as our selected patients in the study 
are unlikely to benefit from non-invasive ventilation. The 
major physiologic defects in COPD are increased dead space, 
severe ventilation-perfusion misdistributions, marked airflow 
limitation, air trapping, and hyperinflation. Such defects fre-
quently result in poor oxygenation and hypercapnia. From the 
initiation of MV the program of weaning must begin, as some 
patients can be successfully weaned from MV within hours 
and for others it may take longer, possibly days or weeks. 
Table 2 The correlations between parameters
pH PaCO2 DSF Hours
spearman’s rho ph R 1.000 -0.405** -0.387** 0.205
P (1-tailed) – 0.002 0.003 0.079
n 73 73 73 73
PaCO2 R -0.405** 1.000 0.367** 0.110
P (1-tailed) 0.002 – 0.005 0.226
n 73 73 73 73
DsF R -0.387** 0.367** 1.000 -0.024
P (1-tailed) 0.003 0.005 – 0.434
n 73 73 73 73
hours R 0.205 0.110 -0.024 1.000
P (1-tailed) 0.079 0.226 0.434 –
n 73 73 73 73
Notes:  *Spearman correlation coefficient test. **Correlation is significant at the 0.01 level (one-tailed).   There is correlation between DSF and PaCO2 and ph but there is 
no correlation between DsF and duration of MV in COPD patients.
Abbreviations: COPD, chronic obstructive pulmonary disease; DsF, dead space fraction; MV, mechanical ventilation; PaCO2, partial pressure of carbon dioxide in arterial 
blood.International Journal of COPD 2009:4 440
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Prolonged MV , especially in COPD exacerbation patients, 
yields a poor chance for weaning.11–13 Complications such 
as pneumonia are frequently encountered in these patients 
especially with prolonged MV .14,15 Other important risk fac-
tors for prolonged MV are severity at admission, ventilator-
associated pneumonia, sepsis and other microbacterial 
findings, barotraumas, acute respiratory distress syndrome, 
cardiovascular and other multiple-organ failure.16
Weaning from mechanical ventilation usually implies 
some closely related aspects of care, discontinuation of 
mechanical ventilation and removal of any artificial airway. 
The first problem that the clinician faces is how to determine 
when a patient is ready to resume ventilation on his or her 
own. Several studies have shown that a direct method of 
assessing readiness to maintain spontaneous breathing is 
simply to initiate a trial of unassisted breathing. Once a 
patient is able to sustain spontaneous breathing, the artificial 
airway can be removed. This decision is made on the basis 
of the patient’s mental status, airway protective mechanisms, 
ability to cough and the amount and the character of secre-
tions and other known criteria. A good number of patients 
with COPD need reintubation immediately or within a short 
time after extubation, studies show rates of approximately 
13%–19% reintubation within the first 48 hours.17
Several studies evaluated the ability to predict the com-
bined outcome of a successful trial of unassisted breathing 
followed by successful weaning in patients with COPD 
exacerbation, and predicted the optimal time for extuba-
tion and the eventual prognosis without the use of invasive 
procedures.18 Few studies have demonstrated the usefulness 
of simple biochemical and clinical markers that need only 
some calculations of the PeCO2 concentration and DSF using 
a simple equation as the Bohr used in our study.8,9
Physiologically in COPD there are abnormalities in 
ventilation and in gas exchange; the consequence would 
be an increase in physiologic dead space and an impaired 
ability to excrete carbon dioxide.9 Lung and cardiovascular 
diseases can lead to elevation in the pulmonary dead space 
fraction and consequently to an increase in respiration work 
and fatigability. These can cause difficulty and failure in the 
weaning process due to abnormalities in the alveolar dead 
space more than the anatomical dead space and elevation in 
the physiologic dead space. Prediction of dead space can be 
used as an index to estimate successful weaning in ventilated 
patients; furthermore, it is an objective monitor of pulmonary 
disease progression.8 Other studies demonstrated the utility 
of DSF measurement at the time of diagnosis in patients with 
acute respiratory distress syndrome (ARDS) and in patients 
with pulmonary embolism.9,19 No other studies succeeded 
in utilizing the measurement of DSF in COPD exacerba-
tion patients as a predictor for weaning from MV . In acute 
respiratory distress syndrome the DSF was a helpful tool for 
prognostic information.1
In this study the aim was to calculate the DSF and to 
demonstrate whether this parameter can be useful in deter-
mining the prognosis and the optimal time for weaning. We 
found a good and significant correlation between DSF and 
PaCO2, an inverse relation between PH and DSF value, PH 
and PaCO2, and no correlation between DSF and the length 
of artificial ventilation. These findings do not contribute to 
the evaluation of the patient’s condition nor do they enable 
us to predict the length of artificial ventilation necessary for 
patients with acute respiratory failure due to COPD exacerba-
tion. More research is necessary to explore the reasons for 
differing patient management and outcomes.
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